Join to View Full Profile
262 Danny Thomas PlMemphis, TN 38105
Phone+1 901-595-3300
Fax+1 901-521-9005
Dr. Federico is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of TennesseeFellowship, Pediatric Hematology/Oncology, 2007 - 2011
Stanford Health Care-Sponsored Stanford UniversityResidency, Pediatrics, 2003 - 2006
Virginia Commonwealth University School of MedicineClass of 2003
Certifications & Licensure
CA State Medical License 2004 - Present
TN State Medical License 2006 - 2026
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Molecular Analysis Of Solid Tumors Start of enrollment: 2010 Feb 10
- Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Start of enrollment: 2019 Mar 04
- Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma Start of enrollment: 2021 Jun 09
- Join now to see all
Publications & Presentations
PubMed
- Outcomes for Patients Aged 12-18 Months With Metastatic MYCN Non-Amplified Neuroblastoma and Unfavorable Biologic Features ("Mixed Biology Toddlers"): A Report From th...Mallory R Taylor, James R Anderson, Julie R Park, Meredith S Irwin, Mark A Applebaum
Pediatric Blood & Cancer. 2025-11-01 - ESFT13: A Phase II Study Evaluating the Addition of Window and Maintenance Therapy to a Standard Chemotherapy Backbone for the Treatment of High-Risk Ewing Sarcoma.Jessica Gartrell, Fariba Navid, Xiaomeng Yuan, Kirsten K Ness, Mikhail Dubrovin
Cancers. 2025-09-03 - Contribution of Germline Predisposition to Pediatric Thyroid Cancer.Claudia Harrison, Alise K Blake, Yin Su, Li Tang, Ninad Oak
Clinical Cancer Research. 2025-09-02
Journal Articles
- Case Report: Management Approach and Use of Extracorporeal Membrane Oxygenation for Diffuse Alveolar Hemorrhage After Pediatric Hematopoietic Cell TransplantSara Federico, Amr Qudeimat, Frontiers in Pediatrics
Press Mentions
Patients with Neuroblastoma See Long-Term Survival Post-PARP Inhibitor, CAR T-cell TreatmentsApril 30th, 2025
First Successful Treatment of Pediatric High-Risk Refractory Neuroblastoma with PARP InhibitionAugust 15th, 2024- 'Bridge' Therapy May Benefit Some Kids with High-Risk NeuroblastomaJune 22nd, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
